Connor, Clark & Lunn Investment Management (CC&L)’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-156,871
| Closed | -$227K | – | 1438 |
|
|
2024
Q4 | $227K | Sell |
156,871
-75,178
| -32% | -$109K | ﹤0.01% | 1301 |
|
|
2024
Q3 | $427K | Buy |
232,049
+524
| +0.2% | +$964 | ﹤0.01% | 1138 |
|
|
2024
Q2 | $232K | Sell |
231,525
-9,275
| -4% | -$9.28K | ﹤0.01% | 1235 |
|
|
2024
Q1 | $477K | Buy |
240,800
+27,835
| +13% | +$55.1K | ﹤0.01% | 1123 |
|
|
2023
Q4 | $332K | Buy |
212,965
+80,173
| +60% | +$125K | ﹤0.01% | 1149 |
|
|
2023
Q3 | $262K | Buy |
132,792
+17,746
| +15% | +$35K | ﹤0.01% | 1178 |
|
|
2023
Q2 | $366K | Buy |
115,046
+92,495
| +410% | +$294K | ﹤0.01% | 1062 |
|
|
2023
Q1 | $73.7K | Buy |
+22,551
| New | +$73.7K | ﹤0.01% | 1178 |
|